Drogueria Saporiti Sacifia Listed by The Gentlemen Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

A ransomware group known as The Gentlemen has listed Drogueria Saporiti Sacifia on its leak site, with the listing reported on September 07, 2026. The company has not publicly confirmed the claim as of writing. For customers, pharmacy partners, suppliers, and employees who may have dealt with this Argentine pharmaceutical wholesaler, the practical question is conditional: if any personal or business information were ever copied and later published, what would that mean and what should you do?

Public detail is limited. The listing does not establish that a breach occurred, does not confirm how many people might be involved, and does not provide a verified inventory of files. What follows treats the group's statements as claims, explains what a listing of this kind does and does not show, and outlines steps worth taking if you have a relationship with the firm.

Inside the listing

According to the leak-site listing attributed to The Gentlemen, Drogueria Saporiti Sacifia appears among organisations the group names publicly. The reported summary associated with the listing claims that about 100GB of data was taken and points to the company's web presence and business profile material. The group has not, in the material provided for this write-up, published a confirmed file-by-file inventory that independent parties have verified.

People affected are listed as unknown. Data types named as exposed are not disclosed in the facts available here. Timing of any alleged intrusion, method of access, and whether any files were actually released beyond the listing itself are undisclosed. A leak-site entry is a form of pressure used in extortion campaigns; it is not the same thing as confirmation by the named organisation, a regulator, or a neutral breach index.

As of writing, Drogueria Saporiti Sacifia has not publicly confirmed the claim. Readers should treat scale figures, slogans, and data descriptions on attacker sites as unverified marketing unless corroborated elsewhere.

Who is The Gentlemen?

The Gentlemen is a ransomware and extortion-style threat actor known in public reporting for encrypting or claiming to exfiltrate data from organisations and then listing victims on a leak site to push for payment. Groups in this category typically combine technical intrusion with public naming, countdown-style pressure, and threats to publish material if demands are not met. Their public posts are designed to create urgency for the named organisation and anxiety for anyone who might appear in business records.

Well-documented patterns for such crews include double-extortion narratives—claiming both disruption inside the network and theft of files—and reuse of branding across many unrelated targets. That general pattern does not prove what happened in any single case. For this listing, the only incident-specific assertions available here are those the group itself advances: that Drogueria Saporiti Sacifia is named, and that the group claims a large volume of data was taken. No independent confirmation of those claims is included in the facts at hand.

About Drogueria Saporiti Sacifia

Drogueria Saporiti Sacifia is described in public business context as a long-established Argentine pharmaceutical wholesaler and manufacturer, with roots presented as dating to 1901 in Buenos Aires and operations associated with the Otero Pose family. Public profile material characterises it as employing on the order of about 110 people, with substantial facilities, a large catalogue of products, and a wide pharmacy client base, alongside wholesale distribution and imports or exports of raw materials. Its Parafarm line is often described in trade context as a familiar set of galenic essentials sold through pharmacies.

Organisations in this role sit between manufacturers, importers, and thousands of pharmacy counters. They routinely handle commercial contracts, shipping and invoicing data, product and batch-related records, and the kinds of identity and contact details needed to run wholesale accounts. A credible compromise in this sector would matter because pharmacy supply chains touch regulated products, business-critical ordering, and sometimes sensitive commercial terms—not because any specific theft has been proven here, but because of how the industry works when records are real.

What data was at risk

The facts state that data types named as exposed are not disclosed. The listing's own marketing language should not be read as a verified catalogue. It is therefore not established which systems, if any, were touched, or whether customer, employee, supplier, or internal manufacturing records were involved.

If files from a pharmaceutical wholesaler of this kind were ever taken, firms in the sector typically hold some mix of the following—again as sector norms, not as a confirmed inventory for this case: business contact details for pharmacy clients and suppliers; account, order, and logistics records; employee or contractor information used for operations; and commercial documents tied to products, pricing, and imports or exports. Whether any of that applies to this listing remains unconfirmed. People affected remain unknown in the available record.

Why it matters

For individuals and small pharmacies, the real-world risk is conditional. If business contact data or account records were copied and later misused, common outcomes in similar sectors include targeted phishing that impersonates a familiar wholesaler, fraudulent invoice or payment redirection attempts, and social-engineering calls that cite real order history to sound legitimate. Identity or employment-related fields, if present in any leaked set, can feed broader fraud attempts over time. None of that is proof that your data is in this listing; it is why people watch these claims carefully.

For the organisation, a public extortion listing can disrupt partner trust and invite scrutiny even when facts are incomplete. A leak-site post establishes that a crew chose to name the company and to claim a volume of data; it does not by itself establish negligence, successful exfiltration, or the accuracy of the claimed size. Separating claim from confirmation is part of reading these events without amplifying unverified accusations.

Steps worth taking either way

Because the incident is unconfirmed and details are thin, the useful posture is precaution without panic. If you buy from, supply, or work with Drogueria Saporiti Sacifia, treat unexpected messages about invoices, password resets, or “urgent breach documents” with extra scepticism until you verify through a known channel.

• If you receive emails or messages that reference this listing, do not open attachments or click links; contact the company or your usual account manager using a phone number or address you already trust.
• If you share passwords across work and personal accounts, change the relevant passwords and turn on multi-factor authentication where you can.
• Watch bank and card statements for unfamiliar charges if you ever paid the firm by card or transferred funds on invoice.
• Pharmacy and small-business staff should agree internally who confirms payment-detail changes so a single urgent email cannot redirect funds.
• Employees or contractors who used company email or HR portals can review account recovery options and be alert for spear-phishing that cites internal jargon.
• Readers can run a free exposure scan of their email to check whether their information has already surfaced in known breach data sets unrelated to this claim.

Public detail on this listing remains limited. The Gentlemen has named Drogueria Saporiti Sacifia and claims a substantial data volume; the company has not publicly confirmed the incident as of writing, affected-person counts are unknown, and exposed data types are not disclosed. Conditional caution—verifying contacts, hardening accounts, and monitoring financial activity—is proportionate until clearer official information appears.

AICompiled with AI assistance from public sources and published under our editorial standards.